NAFCILLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nafcillin, and when can generic versions of Nafcillin launch?
Nafcillin is a drug marketed by Antibiotice, Apothecon, Eugia Pharma Speclts, Fresenius, Istituto Bio Ita Spa, Onesource Specialty, Sagent Pharms, Sandoz, and Watson Labs Inc. and is included in fifteen NDAs.
The generic ingredient in NAFCILLIN is nafcillin sodium. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nafcillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nafcillin
A generic version of NAFCILLIN was approved as nafcillin sodium by ISTITUTO BIO ITA SPA on April 20th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NAFCILLIN?
- What are the global sales for NAFCILLIN?
- What is Average Wholesale Price for NAFCILLIN?
Summary for NAFCILLIN
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 15 |
| Drug Prices: | Drug price information for NAFCILLIN |
| What excipients (inactive ingredients) are in NAFCILLIN? | NAFCILLIN excipients list |
| DailyMed Link: | NAFCILLIN at DailyMed |
US Patents and Regulatory Information for NAFCILLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-001 | Oct 26, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-003 | Oct 26, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Watson Labs Inc | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 062844-004 | Oct 26, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Antibiotice | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 090560-001 | Oct 3, 2011 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Sagent Pharms | NAFCILLIN SODIUM | nafcillin sodium | INJECTABLE;INJECTION | 090582-001 | Aug 24, 2012 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
